â– LECTURE OVERVIEW: Organophosphate poisoning is a life-threatening toxidrome resulting from severe, uninhibited acetylcholinesterase inactivation that triggers massive cholinergic hyperstimulation.
â– MOLECULAR TOXICOLOGY & ACTIONS:
1. Phosphorylation of active site: Organophosphates (found in agricultural insecticides like parathion, malathion and nerve gases like sarin) bind covalently to the serine hydroxyl group of acetylcholinesterase (AChE), neutralizing the enzyme.
2. Acetylcholine Overdrive: Acetylcholine accumulates in synaptic clefts across muscarinic, nicotinic, and central nervous system synapses.
3. Cholinergic Excess (DUMBBELSS): Drives a massive cholinergic crisis: Diarrhea, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation, and Sweating. Nicotinic accumulation causes muscle fasciculations, muscle fatigue, flaccid paralysis (diaphragm failure), and central respiratory depression.
4. Chemical Aging: Over hours, the covalent bond undergo dealkylation ('aging'), rendering the AChE chemical blockade completely permanent and irreversible.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– EVIDENCE-BASED GUIDELINE SYNOPSIS:
Recent international multi-center guidelines emphasize starting therapeutic interventions immediately upon diagnosis to minimize long-term target organ strain.
[HY-BOARD-1056]
🌟 Dynamic Clinical Key:
Management requires a rapid, dual-action antidote: Atropine (a competitive muscarinic blocker) to address life-threatening bradycardia and bronchospasm, and Pralidoxime (2-PAM), an oxime compound designed to dephosphorylate and regenerate active AChE. Crucially, Pralidoxime must be administered before AChE 'aging' occurs to be effective. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Consult updated medical consensus reports to align treatment protocols with modern precision standards.